Metoprolol, a beta-1 selective blocker, can be used safely in coronary artery disease patients with chronic obstructive pulmonary disease. 2003

Ahmet Camsari, and Serpil Arikan, and Candan Avan, and Deniz Kaya, and Hasan Pekdemir, and Dilek Ciçek, and Ahmet Kiykim, and Kerem Sezer, and Necdet Akkuş, and Mehmet Alkan, and Sinan Aydoğdu
Department of Cardiology, Faculty of Medicine, University of Mersin, 33070, Mersin, Turkey. ahmetcamsari@hotmail.com

The coexistence of coronary artery disease (CAD) and chronic obstructive pulmonary disease (COPD) is frequent because of common etiological factors. Beta-blockers remain underutilized in patients with CAD who also have COPD. This study was performed to evaluate the safety of beta-1 selective blocker agents in CAD patients with COPD. Fifty patients (aged 57.3 +/- 10.1 years) were enrolled in this study; 27 patients received metoprolol CR (controlled release), and 23 received metoprolol (conventional). The patients were stratified according to the severity of COPD (21 severe, 21 moderate, and 8 mild), started on metoprolol CR or conventional metoprolol, and titrated up to the maximum tolerated dose. The clinical controls were done during the first week and then at the first and third month. Patients received a mean total daily dose of 92.5 +/- 18 mg of metoprolol CR or 189 +/- 36.7 mg of metoprolol. Seven patients could not receive the maximum dose. There was no significant decrease in forced expiratory volume in 1 s (FEV(1)) in either group (basal vs last FEV(1): 54.5% +/- 13.4% vs 54.3% +/- 13% in the metoprolol CR group and 49.6% +/- 14.5% vs 53.2% +/- 12.8% in the metoprolol group). No adverse event was experienced. Metoprolol, a beta-1 selective blocker, can be used safely at the maximum dose in CAD patients with COPD.

UI MeSH Term Description Entries
D008297 Male Males
D008790 Metoprolol A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS. Beloc-Duriles,Betaloc,Betaloc-Astra,Betalok,CGP-2175,H 93-26,Lopressor,Metoprolol CR-XL,Metoprolol Succinate,Metoprolol Tartrate,Seloken,Spesicor,Spesikor,Toprol,Toprol-XL,Beloc Duriles,Betaloc Astra,CGP 2175,CGP2175,H 93 26,H 9326,Metoprolol CR XL,Toprol XL
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D005260 Female Females
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000319 Adrenergic beta-Antagonists Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. Adrenergic beta-Antagonist,Adrenergic beta-Receptor Blockader,Adrenergic beta-Receptor Blockaders,beta-Adrenergic Antagonist,beta-Adrenergic Blocker,beta-Adrenergic Blocking Agent,beta-Adrenergic Blocking Agents,beta-Adrenergic Receptor Blockader,beta-Adrenergic Receptor Blockaders,beta-Adrenoceptor Antagonist,beta-Blockers, Adrenergic,beta-Adrenergic Antagonists,beta-Adrenergic Blockers,beta-Adrenoceptor Antagonists,Adrenergic beta Antagonist,Adrenergic beta Antagonists,Adrenergic beta Receptor Blockader,Adrenergic beta Receptor Blockaders,Adrenergic beta-Blockers,Agent, beta-Adrenergic Blocking,Agents, beta-Adrenergic Blocking,Antagonist, beta-Adrenergic,Antagonist, beta-Adrenoceptor,Antagonists, beta-Adrenergic,Antagonists, beta-Adrenoceptor,Blockader, Adrenergic beta-Receptor,Blockader, beta-Adrenergic Receptor,Blockaders, Adrenergic beta-Receptor,Blockaders, beta-Adrenergic Receptor,Blocker, beta-Adrenergic,Blockers, beta-Adrenergic,Blocking Agent, beta-Adrenergic,Blocking Agents, beta-Adrenergic,Receptor Blockader, beta-Adrenergic,Receptor Blockaders, beta-Adrenergic,beta Adrenergic Antagonist,beta Adrenergic Antagonists,beta Adrenergic Blocker,beta Adrenergic Blockers,beta Adrenergic Blocking Agent,beta Adrenergic Blocking Agents,beta Adrenergic Receptor Blockader,beta Adrenergic Receptor Blockaders,beta Adrenoceptor Antagonist,beta Adrenoceptor Antagonists,beta Blockers, Adrenergic,beta-Antagonist, Adrenergic,beta-Antagonists, Adrenergic,beta-Receptor Blockader, Adrenergic,beta-Receptor Blockaders, Adrenergic

Related Publications

Ahmet Camsari, and Serpil Arikan, and Candan Avan, and Deniz Kaya, and Hasan Pekdemir, and Dilek Ciçek, and Ahmet Kiykim, and Kerem Sezer, and Necdet Akkuş, and Mehmet Alkan, and Sinan Aydoğdu
January 2009, Heart & lung : the journal of critical care,
Ahmet Camsari, and Serpil Arikan, and Candan Avan, and Deniz Kaya, and Hasan Pekdemir, and Dilek Ciçek, and Ahmet Kiykim, and Kerem Sezer, and Necdet Akkuş, and Mehmet Alkan, and Sinan Aydoğdu
September 2015, Ugeskrift for laeger,
Ahmet Camsari, and Serpil Arikan, and Candan Avan, and Deniz Kaya, and Hasan Pekdemir, and Dilek Ciçek, and Ahmet Kiykim, and Kerem Sezer, and Necdet Akkuş, and Mehmet Alkan, and Sinan Aydoğdu
November 2007, Annales de cardiologie et d'angeiologie,
Ahmet Camsari, and Serpil Arikan, and Candan Avan, and Deniz Kaya, and Hasan Pekdemir, and Dilek Ciçek, and Ahmet Kiykim, and Kerem Sezer, and Necdet Akkuş, and Mehmet Alkan, and Sinan Aydoğdu
February 2019, Revue des maladies respiratoires,
Ahmet Camsari, and Serpil Arikan, and Candan Avan, and Deniz Kaya, and Hasan Pekdemir, and Dilek Ciçek, and Ahmet Kiykim, and Kerem Sezer, and Necdet Akkuş, and Mehmet Alkan, and Sinan Aydoğdu
January 2014, European journal of clinical investigation,
Ahmet Camsari, and Serpil Arikan, and Candan Avan, and Deniz Kaya, and Hasan Pekdemir, and Dilek Ciçek, and Ahmet Kiykim, and Kerem Sezer, and Necdet Akkuş, and Mehmet Alkan, and Sinan Aydoğdu
January 2011, International journal of cardiology,
Ahmet Camsari, and Serpil Arikan, and Candan Avan, and Deniz Kaya, and Hasan Pekdemir, and Dilek Ciçek, and Ahmet Kiykim, and Kerem Sezer, and Necdet Akkuş, and Mehmet Alkan, and Sinan Aydoğdu
August 1998, American heart journal,
Ahmet Camsari, and Serpil Arikan, and Candan Avan, and Deniz Kaya, and Hasan Pekdemir, and Dilek Ciçek, and Ahmet Kiykim, and Kerem Sezer, and Necdet Akkuş, and Mehmet Alkan, and Sinan Aydoğdu
December 2012, International journal of STD & AIDS,
Ahmet Camsari, and Serpil Arikan, and Candan Avan, and Deniz Kaya, and Hasan Pekdemir, and Dilek Ciçek, and Ahmet Kiykim, and Kerem Sezer, and Necdet Akkuş, and Mehmet Alkan, and Sinan Aydoğdu
November 2005, Pharmacotherapy,
Ahmet Camsari, and Serpil Arikan, and Candan Avan, and Deniz Kaya, and Hasan Pekdemir, and Dilek Ciçek, and Ahmet Kiykim, and Kerem Sezer, and Necdet Akkuş, and Mehmet Alkan, and Sinan Aydoğdu
January 2017, Journal of Ayub Medical College, Abbottabad : JAMC,
Copied contents to your clipboard!